Kassem S Faraj (Kassem Faraj)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Topics

Oxide Nanoparticles

Health Insurance

Radical Prostatectomy

Top Venues

Cancer medicine

International urology and nephrology

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Xinyu Liang, Ziwei Zhu, Kassem S Faraj, Vahakn B Shahinian, Brent K Hollenbeck, Lindsey A Herrel
Quality of care for dual eligible beneficiaries in the oncology care model. Cancer medicine 13 (14) (2024)
Kassem S Faraj, Mary Oerline, Samuel R Kaufman, Christopher Dall, Arnav Srivastava, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitors. Journal of the National Cancer Institute (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer 130 (18) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program. Cancer (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Xinyu Liang, Ziwei Zhu, Kassem S Faraj, Vahakn B Shahinian, Brent K Hollenbeck, Lindsey A Herrel
Quality of care for dual eligible beneficiaries in the oncology care model. Cancer medicine 13 (14) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer (2024)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Anojan K Navaratnam, Sarah Eversman, Laila Elias, Amit Syal, Mark D Tyson, Erik P Castle
Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer. International urology and nephrology 53 (6) (2021)
Kassem S Faraj, Victoria S Edmonds, Sam L Snider, Weslyn D Bunn, Mark D Tyson
Timing of perioperative transversus abdominis plane block at the time of radical cystectomy does not affect perioperative outcomes. International urology and nephrology 53 (10) (2021)
Kassem S Faraj, Nathanael Judge, Yu-Hui H Chang, Gail Blodgett, Melissa L Stanton, Mark D Tyson
Variation in Lymph Node Yield After Radical Cystectomy. American journal of clinical pathology 156 (3) (2021)
Kassem S Faraj, Kyle M Rose, Anojan K Navaratnam, Haidar M Abdul-Muhsin, Sarah Eversman, Vijay Singh, Mark D Tyson
Effect of intracorporeal urinary diversion on the incidence of benign ureteroenteric stricture after cystectomy. International journal of urology : official journal of the Japanese Urological Association 28 (5) (2021)
Amihay Nevo, Kassem S Faraj, Scott M Cheney, Jonathan P Moore, Karen L Stern, Michael Borofsky, Ehud Gnessin, Mitchell R Humphreys
Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses: a randomised controlled trial. BJU international 127 (5) (2020)